A €52m investment in a leading dental technologies firm (May 2018)
Ceres Industries sourced the €52m investment opportunity and brought in, as co-investor, a €5,6Bn family-controlled investment holding with a "patient capital" approach in line with the one of Ceres.
About Biotech Dental (“BD”)
Created by Philippe Veran, BD was historically a leading European manufacturer of dental implants. Through JVs with high tech players - such as the MIT award winning artificial intelligence specialist, Anatoscope, or the most disruptive intra-oral scanner, CondorScan - and R&D investments to create internal start-ups (such as SMILERS®, the # 1 invisible aligner in France, and CIRCLE, which has developed a unique and patented prosthetic manufacturing method leader, combining 3D software conception and addictive manufacturing), BD has gone from being a specialist in implantology to a digital leader across all main product lines.
Ceres Value added
Ceres management experience and track-record of developing Alkapharm’ s dental businesses in 15 countries.
Ceres committed to open selected Asian and European markets.
“ I was quickly attracted by Ceres Industries’ differentiated approach to investing and their experienced team of former CEOs. Very different from most PE funds which had been courting us. Ceres’ team knows our industry well and was able to bring operational value added early on. They delivered on their commitment to open large international markets for Biotech Dental by giving us direct access to leading players".